Students evacuated after bomb threat at South Haven High School  SOUTH HAVEN, Mich. (NEWSCHANNEL 3) - Police are on the scene of a bomb threat at the South Haven High School.

BREAKING NEWS
[an error occurred while processing this directive]

Pfizer settles Protonix patent case for $2.15B

Updated: Wednesday, June 12, 2013 |
Pfizer settles Protonix patent case for $2.15B story image
NEW YORK (AP) - Pfizer says it has reached a $2.15 billion settlement with a couple of generic drugmakers over sales of their versions of the heartburn drug Protonix.
   
The world's second-largest drugmaker says Teva Pharmaceutical Industries will pay $1.6 billion to Pfizer and Japanese drugmaker Takeda Pharmaceutical.
   
Another generic drugmaker, Sun Pharmaceutical Industries, will pay $550 million.
   
Teva is one of the world's largest generic drugmakers. It started selling its generic version of Protonix in December 2007. Sun launched its own version in early 2008. The drug's U.S. patent expired in 2011.
   
Drugmaker Nycomed developed Protonix before the company was purchased by Takeda. Nycomed licensed Protonix to Wyeth, which Pfizer has since purchased.
   
Pfizer says it will receive 64 percent of the settlement proceeds.
comments powered by Disqus
advertisement
Washington Times
advertisement